jeffrey w ubben  wikipedia jeffrey w ubben from wikipedia the free encyclopedia jump to navigation search jeffrey w ubben born jeffrey williams ubben  age – nationality american alma mater duke university kellogg school of management occupation businessman net worth us million  jeffrey williams ubben born  is an american businessman he is the cofounder chief executive officer and chief investment officer of valueact capital a hedge fund based in san francisco california contents  early life  business career  philanthropy  references early lifeedit jeffrey w ubben graduated from duke university he received a master of business administration from the kellogg school of management at northwestern university in  business careeredit ubben managed the fidelity value fund at fidelity investments for eight years he served as the managing partner of blum capital from  to  ubben is the cofounder of valueact capital a hedge fund based in san francisco california in  he serves as its chief executive officer and chief investment officer ubben formerly served on the boards of directors of acxiom gartner misys omnicare and the sara lee corporation he serves on the board of directors of the willis group in september  he was nominated to serve on the board of directors of st century fox in august  ubben acquired a minority stake in the united talent agency philanthropyedit ubben serves as the chair of the national board of directors of the posse foundation he serves on the boards of trustees of northwestern university and the american conservatory theater referencesedit  a b c d e f company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     ones to watch jeff urban forbes retrieved  october    a b c farell rachel alumni profiles jeff ubben ’ kellogg school of management retrieved october     a b c board of directors about willis retrieved october     hagey keach benoit david september   fox nominates valueact ceo jeffrey ubben to board ubben says netflix’s industry impact is catalyst for ‘fundamental change in strategy’ the wall street journal retrieved october     lang brent september   st century fox taps investor jeffrey ubben to join board variety retrieved october     barnes brooks august   jeffrey ubben buys minority stake in united talent agency the new york times retrieved october     company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     trustees northwestern university retrieved october     board of trustees american conservatory theater retrieved october    retrieved from httpsenwikipediaorgwindexphptitlejeffreywubbenoldid categories  birthsliving peopleduke university alumnikellogg school of management alumniamerican company foundersamerican chief executivesamerican hedge fund managersamerican corporate directorschief investment officershidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view jeffrey w ubben  wikipedia jeffrey w ubben from wikipedia the free encyclopedia jump to navigation search jeffrey w ubben born jeffrey williams ubben  age – nationality american alma mater duke university kellogg school of management occupation businessman net worth us million  jeffrey williams ubben born  is an american businessman he is the cofounder chief executive officer and chief investment officer of valueact capital a hedge fund based in san francisco california contents  early life  business career  philanthropy  references early lifeedit jeffrey w ubben graduated from duke university he received a master of business administration from the kellogg school of management at northwestern university in  business careeredit ubben managed the fidelity value fund at fidelity investments for eight years he served as the managing partner of blum capital from  to  ubben is the cofounder of valueact capital a hedge fund based in san francisco california in  he serves as its chief executive officer and chief investment officer ubben formerly served on the boards of directors of acxiom gartner misys omnicare and the sara lee corporation he serves on the board of directors of the willis group in september  he was nominated to serve on the board of directors of st century fox in august  ubben acquired a minority stake in the united talent agency philanthropyedit ubben serves as the chair of the national board of directors of the posse foundation he serves on the boards of trustees of northwestern university and the american conservatory theater referencesedit  a b c d e f company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     ones to watch jeff urban forbes retrieved  october    a b c farell rachel alumni profiles jeff ubben ’ kellogg school of management retrieved october     a b c board of directors about willis retrieved october     hagey keach benoit david september   fox nominates valueact ceo jeffrey ubben to board ubben says netflix’s industry impact is catalyst for ‘fundamental change in strategy’ the wall street journal retrieved october     lang brent september   st century fox taps investor jeffrey ubben to join board variety retrieved october     barnes brooks august   jeffrey ubben buys minority stake in united talent agency the new york times retrieved october     company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     trustees northwestern university retrieved october     board of trustees american conservatory theater retrieved october    retrieved from httpsenwikipediaorgwindexphptitlejeffreywubbenoldid categories  birthsliving peopleduke university alumnikellogg school of management alumniamerican company foundersamerican chief executivesamerican hedge fund managersamerican corporate directorschief investment officershidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view jeffrey w ubben  wikipedia jeffrey w ubben from wikipedia the free encyclopedia jump to navigation search jeffrey w ubben born jeffrey williams ubben  age – nationality american alma mater duke university kellogg school of management occupation businessman net worth us million  jeffrey williams ubben born  is an american businessman he is the cofounder chief executive officer and chief investment officer of valueact capital a hedge fund based in san francisco california contents  early life  business career  philanthropy  references early lifeedit jeffrey w ubben graduated from duke university he received a master of business administration from the kellogg school of management at northwestern university in  business careeredit ubben managed the fidelity value fund at fidelity investments for eight years he served as the managing partner of blum capital from  to  ubben is the cofounder of valueact capital a hedge fund based in san francisco california in  he serves as its chief executive officer and chief investment officer ubben formerly served on the boards of directors of acxiom gartner misys omnicare and the sara lee corporation he serves on the board of directors of the willis group in september  he was nominated to serve on the board of directors of st century fox in august  ubben acquired a minority stake in the united talent agency philanthropyedit ubben serves as the chair of the national board of directors of the posse foundation he serves on the boards of trustees of northwestern university and the american conservatory theater referencesedit  a b c d e f company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     ones to watch jeff urban forbes retrieved  october    a b c farell rachel alumni profiles jeff ubben ’ kellogg school of management retrieved october     a b c board of directors about willis retrieved october     hagey keach benoit david september   fox nominates valueact ceo jeffrey ubben to board ubben says netflix’s industry impact is catalyst for ‘fundamental change in strategy’ the wall street journal retrieved october     lang brent september   st century fox taps investor jeffrey ubben to join board variety retrieved october     barnes brooks august   jeffrey ubben buys minority stake in united talent agency the new york times retrieved october     company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     trustees northwestern university retrieved october     board of trustees american conservatory theater retrieved october    retrieved from httpsenwikipediaorgwindexphptitlejeffreywubbenoldid categories  birthsliving peopleduke university alumnikellogg school of management alumniamerican company foundersamerican chief executivesamerican hedge fund managersamerican corporate directorschief investment officershidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view jeffrey w ubben  wikipedia jeffrey w ubben from wikipedia the free encyclopedia jump to navigation search jeffrey w ubben born jeffrey williams ubben  age – nationality american alma mater duke university kellogg school of management occupation businessman net worth us million  jeffrey williams ubben born  is an american businessman he is the cofounder chief executive officer and chief investment officer of valueact capital a hedge fund based in san francisco california contents  early life  business career  philanthropy  references early lifeedit jeffrey w ubben graduated from duke university he received a master of business administration from the kellogg school of management at northwestern university in  business careeredit ubben managed the fidelity value fund at fidelity investments for eight years he served as the managing partner of blum capital from  to  ubben is the cofounder of valueact capital a hedge fund based in san francisco california in  he serves as its chief executive officer and chief investment officer ubben formerly served on the boards of directors of acxiom gartner misys omnicare and the sara lee corporation he serves on the board of directors of the willis group in september  he was nominated to serve on the board of directors of st century fox in august  ubben acquired a minority stake in the united talent agency philanthropyedit ubben serves as the chair of the national board of directors of the posse foundation he serves on the boards of trustees of northwestern university and the american conservatory theater referencesedit  a b c d e f company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     ones to watch jeff urban forbes retrieved  october    a b c farell rachel alumni profiles jeff ubben ’ kellogg school of management retrieved october     a b c board of directors about willis retrieved october     hagey keach benoit david september   fox nominates valueact ceo jeffrey ubben to board ubben says netflix’s industry impact is catalyst for ‘fundamental change in strategy’ the wall street journal retrieved october     lang brent september   st century fox taps investor jeffrey ubben to join board variety retrieved october     barnes brooks august   jeffrey ubben buys minority stake in united talent agency the new york times retrieved october     company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     trustees northwestern university retrieved october     board of trustees american conservatory theater retrieved october    retrieved from httpsenwikipediaorgwindexphptitlejeffreywubbenoldid categories  birthsliving peopleduke university alumnikellogg school of management alumniamerican company foundersamerican chief executivesamerican hedge fund managersamerican corporate directorschief investment officershidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view jeffrey w ubben  st century fox cf twitter cf twitter cf blog rss search form search search search search form search jeffrey w ubben jeffrey w ubbenfounder ceo and chief investment officervalueact capital jeffrey w ubben is a founder chief executive officer and the chief investment officer of valueact capital  mr ubben is a director of willis group holdings plc a former chairman and director of martha stewart living omnimedia inc and a former director of catalina marketing corp gartner group inc mentor corporation misys plc sara lee corp valeant pharmaceuticals international and several other public and private companies  in addition mr ubben serves as chairman of the national board of the posse foundation is on the board of trustees of duke university and is also on the board of trustees of northwestern university  he has a ba from duke university and an mba from the j l kellogg graduate school of management at northwestern university mr ubben has been a director of st century fox since november  jeffrey w ubben quizzes  lists  trending sign up  login feedback jeffrey w ubben topics  videos  discussion  writeups back to top  revolvy llc mobile terms privacy contact paste image information here × image source save changes × cancel  × × done cancel by proceeding i agree to the revolvy terms of service and privacy policy ok cancel ok cancel × ok cancel × ok cancel × ok cancel × save cancel × ok clear cancel × ok clear cancel jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals  marketwatch latest news dow    nasdaq    sp      pm et charges dropped after ‘london whale’ accused jamie dimon of making him a fall guy  pm et goodbye sean spicer memorable moments from the podium  pm et how to fix wall street and bankers pay  pm et amazon whole foods look to head off lengthy deal review  pm et hawaii adopts emergency plan for north korea missile attack  pm et california wildfire destroys homes near yosemite  pm et spicer quits as scaramucci accepts white house job  pm et updated why you shouldn’t order ice on a flight and other ‘dirty little secrets’  pm et updated if you’re reading this you have a  chance of being rich  pm et updated  unfortunate reasons why millennials can’t have nice things or save any money  pm et updated this is the deadliest time of your life to put on weight  pm et updated if like sean spicer you suddenly walk out — what should you do next  pm et a history of sears through highs and lows  pm et are you a money bully  pm et how realestate tv shows determine what home buyers look for and what to do if you decide to quit your job like sean spicer  pm et updated wall streets fear gaugethe vixjust logged its secondlowest close in history  pm et updated why it might be time to invest in the companies amazon is destroying  pm et updated this is what should really worry you about stocks  pm et updated beware of the curse of the number  in the stock market  pm et sp  nasdaq post weekly gains as stock market finishes session lower log in home cnw group get email alerts jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals by published sept    am et share laval quebec sep   canada newswire via comtex  valeant pharmaceuticals international inc nysetsxvrx today announced that its board of directors has appointed jeffrey w ubben founder chief executive officer and the chief investment officer of valueact capital as a director of the board effective as of october   mr ubben is a founder chief executive officer and the chief investment officer of valueact capital prior to founding valueact capital in  mr ubben was a managing partner at blum capital partners for more than five years mr ubben is a director of willis group holdings plc a former chairman and director of martha stewart living omnimedia inc and a former director of acxiom corp catalina marketing corp gartner group inc insurance auto auctions inc mentor corporation omnicare inc misys plc perse technologies inc sara lee corp and several other public and private companies in addition mr ubben serves as chairman of the national board of the posse foundation is on the board of trustees of northwestern university and is also on the board of the american conservatory theater mr ubben has a ba from duke university and an mba from the j l kellogg graduate school of management at northwestern university valueact is delighted to once again be a part of the valeant board of directors stated jeffrey w ubben chief executive officer of valueact capital valeant has been an important component to valueacts success over the past seven years and we strongly believe in valeants business model and strategy valeant has become significantly undervalued on a standalone basis due to recent unjustified attacks on the company we are strongly supportive of the allerganvaleant combination in light of their perfect strategic fit and the potential to create enormous shareholder value for both companies valueact has not reduced its position in valeant since leaving the board in may and we expect to increase our already substantial position in valeant i look forward to working with mike and the board of directors to help secure the allergan transaction and then continuing to serve on the board to deliver longterm value to all shareholders it is a privilege and an honor to have jeff as valueacts most senior partner and the chief executive officer of valueact join our board stated j michael pearson chairman and chief executive officer of valeant jeff believes in valeants longterm potential and his expertise and counsel as a committed longterm valeant shareholder will be invaluable to me personally as well as to the entire board as we continue to execute on our strategy to become a leading pharmaceutical company it is incredibly valuable to have such a highly respected firm such as valueact whose focus is on longterm value creation to be completely aligned with us as we execute our strategy about valeant pharmaceuticals international inc valeant pharmaceuticals international inc nysetsxvrx is a multinational specialty pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology eye health neurology and branded generics more information about valeant can be found at wwwvaleantcom forwardlooking statements this communication may contain forwardlooking statements within the meaning of the private securities litigation reform act of  and canadian securities laws these forwardlooking statements include but are not limited to statements regarding valeants offer to acquire allergan its financing of the proposed transaction its expected future performance including expected results of operations and financial guidance and the combined companys future financial condition operating results strategy and plans forwardlooking statements may be identified by the use of the words anticipates expects intends plans should could would may will believes estimates potential target opportunity tentative positioning designed create predict project seek ongoing upside increases or continue and variations or similar expressions these statements are based upon the current expectations and beliefs of management and are subject to numerous assumptions risks and uncertainties that change over time and could cause actual results to differ materially from those described in the forwardlooking statements these assumptions risks and uncertainties include but are not limited to assumptions risks and uncertainties discussed in the companys most recent annual or quarterly report filed with the sec and the canadian securities administrators the csa and assumptions risks and uncertainties relating to the proposed merger as detailed from time to time in valeants filings with the sec and the csa which factors are incorporated herein by reference important factors that could cause actual results to differ materially from the forwardlooking statements we make in this communication are set forth in other reports or documents that we file from time to time with the sec and the csa and include but are not limited to  the ultimate outcome of the offer and the secondstep merger including the ultimate removal or the failure to render inapplicable the obstacles to consummation of the offer and the secondstep merger described in the offer to exchange  the ultimate outcome and results of integrating the operations of valeant and allergan the ultimate outcome of valeants pricing and operating strategy applied to allergan and the ultimate ability to realize synergies  the effects of the proposed combination of valeant and allergan including the combined companys future financial condition operating results strategy and plans  the effects of governmental regulation on our business or potential business combination transactions  the ability to obtain regulatory approvals and meet other conditions to the offer including the necessary stockholder approval on a timely basis  valeants ability to sustain and grow revenues and cash flow from operations in our markets and to maintain and grow our customer base the need for innovation and the related capital expenditures and the unpredictable economic conditions in the united states and other markets  the impact of competition from other market participants  the development and commercialization of new products  the availability and access in general of funds to meet our debt obligations prior to or when they become due and to fund our operations and necessary capital expenditures either through i cash on hand ii free cash flow or iii access to the capital or credit markets  our ability to comply with all covenants in our indentures and credit facilities any violation of which if not cured in a timely manner could trigger a default of our other obligations under crossdefault provisions and  the risks and uncertainties detailed by allergan with respect to its business as described in its reports and documents filed with the sec all forwardlooking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by this cautionary statement readers are cautioned not to place undue reliance on any of these forwardlooking statements these forwardlooking statements speak only as of the date hereof valeant undertakes no obligation to update any of these forwardlooking statements to reflect events or circumstances after the date of this communication or to reflect actual outcomes additional information this communication does not constitute an offer to buy or solicitation of an offer to sell any securities this communication relates to the exchange offer which valeant has made to allergan stockholders the exchange offer is being made pursuant to a tender offer statement on schedule to including the offer to exchange the letter of election and transmittal and other related offer materials and a registration statement on form s filed by valeant with the sec on june   and with the csa as each may be amended from time to time these materials contain important information including the terms and conditions of the offer in addition valeant has filed a preliminary proxy statement with the sec on june   as may be amended from time to time pershing square capital management lp pershing square has filed a definitive proxy statement with the sec on september   and valeant and pershing square and if a negotiated transaction is agreed allergan may file one or more additional proxy statements or other documents with the sec this communication is not a substitute for any proxy statement registration statement prospectus or other document valeant pershing square andor allergan have filed or may file with the sec in connection with the proposed transaction investors and security holders of valeant and allergan are urged to read the tender offer statement registration statement and any other documents filed with the sec carefully in their entirety if and when they become available as they will contain important information about the proposed transaction any definitive proxy statements if and when available will be mailed to stockholders of allergan andor valeant as applicable investors and security holders may obtain free copies of the tender offer statement the registration statement and other documents if and when available filed with the sec by valeant andor pershing square through the web site maintained by the sec at httpwwwsecgov information regarding the names and interests in allergan and valeant of valeant and persons related to valeant who may be deemed participants in any solicitation of allergan or valeant shareholders in respect of a valeant proposal for a business combination with allergan is available in the additional definitive proxy soliciting materials in respect of allergan filed with the sec by valeant on april   may   and september   information regarding the names and interests in allergan and valeant of pershing square and persons related to pershing square who may be deemed participants in any solicitation of allergan or valeant shareholders in respect of a valeant proposal for a business combination with allergan is available in additional definitive proxy soliciting material in respect of allergan filed with the sec by pershing square the additional definitive proxy soliciting material referred to in this paragraph can be obtained free of charge from the sources indicated above contact information valeant pharmaceuticals investors media laurie w little renee e sotomeghan gavigan valeant pharmaceuticals international inc sard verbinnen  co   laurielittlevaleantcom rsotosardverbcom  mgavigansardverbcom httpphotosprnewswirecomprnvarlalogo logo  httpphotosprnewswirecomprnhlalogo source valeant pharmaceuticals international inc source valeant pharmaceuticals international inc source valueact capital copyright c  cnw group all rights reserved more from marketwatch most popular the dark side of cruises the reason jack bogle doesn’t fly first class says everything about his investing legacy oj simpson made over  while in prison and won’t have to give any of it to the goldman family if you’re reading this you have a  chance of being rich  luxury pool floats to class up your instagram marketwatch partner center we want to hear from you join the conversation comment sponsored headlines advanced search stocks columns authors topics no results found marketwatchcom topics bulletin investor alert topics istanbul brexit guns millennials immigration apple congatopicsmainhtml  subjects in the news capital gains tax credit hedge funds income income tax taxation taxes environment markets sales aerospace oil earnings brain politics and government restaurants airlines china people in the news cohen david cohen steven einhorn david trump donald rose stuart jones russell obama barack putin vladimir musk elon williams brian williams michael jones brian williams james lynch michael jones edward clooney george rubin robert tillerson rex companies in the news jones general electric honeywell international inc travel capital group of companies performance miners international data group baker hughes bank of america corp colgatepalmolive dow jones  co ebay inc home depot microsoft corp news corp schlumberger ltd advanced micro devices organizations in the news european central bank european union world bank nasdaq stock market world trade organization opec federal reserve bank of new york new york stock exchange congress gazprom united nations university of california harvard university university of michigan boston university national institutes of health northwestern university university of chicago browse topics a b c d e f g h i j k l m n o p q r s t u v w x y z  log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pcharges dropped after ‘london whale’ accused jamie dimon of making him a fall guy pgoodbye sean spicer memorable moments from the podium phow to fix wall street and bankers pay pamazon whole foods look to head off lengthy deal review phawaii adopts emergency plan for north korea missile attack p california wildfire destroys homes near yosemite pspicer quits as scaramucci accepts white house job pwhy you shouldn’t order ice on a flight and other ‘dirty little secrets’ pif you’re reading this you have a  chance of being rich p unfortunate reasons why millennials can’t have nice things or save any money pthis is the deadliest time of your life to put on weight pif like sean spicer you suddenly walk out — what should you do next pa history of sears through highs and lows pare you a money bully phow realestate tv shows determine what home buyers look for and what to do if you decide to quit your job like sean spicer pbreakingwall streets fear gaugethe vixjust logged its secondlowest close in history pwhy it might be time to invest in the companies amazon is destroying pthis is what should really worry you about stocks pbeware of the curse of the number  in the stock market psp  nasdaq post weekly gains as stock market finishes session lower loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals – valeant skip to main content investor relations homestock information stock charthistorical price lookupinvestment calculatoradvanced fundamentals annual reports archivecorporate governance board of directorscommitteesgovernance documentssec filings analyst coveragenews releases events and presentationsinvestor information financial tear sheetshareholder servicesdocument requestsir and communications contactsemail alerts menu contact us locations home about valeant operational expertise investor relations career opportunities close investor relations homestock information stock charthistorical price lookupinvestment calculatoradvanced fundamentals annual reports archive corporate governance board of directorscommitteesgovernance documentssec filings analyst coveragenews releases events and presentationsinvestor information financial tear sheetshareholder servicesdocument requestsir and communications contactsemail alerts additional tools email page rss feeds home » investor relations » news releases »  » jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals share facebook googleplus twitter linkedin jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals september   laval quebec sept   prnewswire  valeant pharmaceuticals international inc nysetsx vrx today announced that its board of directors has appointed jeffrey w ubben founder chief executive officer and the chief investment officer of valueact capital as a director of the board effective as of october   mr ubben is a founder chief executive officer and the chief investment officer of valueact capital prior to founding valueact capital in  mr ubben was a managing partner at blum capital partners for more than five years  mr ubben is a director of willis group holdings plc a former chairman and director of martha stewart living omnimedia inc and a former director of acxiom corp catalina marketing corp gartner group inc insurance auto auctions inc mentor corporation omnicare inc misys plc perse technologies inc sara lee corp and several other public and private companies  in addition mr ubben serves as chairman of the national board of the posse foundation is on the board of trustees of northwestern university and is also on the board of the american conservatory theater  mr ubben has a ba from duke university and an mba from the j l kellogg graduate school of management at northwestern university valueact is delighted to once again be a part of the valeant board of directors stated jeffrey w ubben chief executive officer of valueact capital  valeant has been an important component to valueacts success over the past seven years and we strongly believe in valeants business model and strategy valeant has become significantly undervalued on a standalone basis due to recent unjustified attacks on the company  we are strongly supportive of the allerganvaleant combination in light of their perfect strategic fit and the potential to create enormous shareholder value for both companies  valueact has not reduced its position in valeant since leaving the board in may and we expect to increase our already substantial position in valeant i look forward to working with mike and the board of directors to help secure the allergan transaction and then continuing to serve on the board to deliver longterm value to all shareholders it is a privilege and an honor to have jeff as valueacts most senior partner and the chief executive officer of valueact join our board stated j michael pearson chairman and chief executive officer of valeant  jeff believes in valeants longterm potential and his expertise and counsel as a committed longterm valeant shareholder will be invaluable to me personally as well as to the entire board as we continue to execute on our strategy to become a leading pharmaceutical company  it is incredibly valuable to have such a highly respected firm such as valueact whose focus is on longterm value creation to be completely aligned with us as we execute our strategy about valeant pharmaceuticals international inc valeant pharmaceuticals international inc nysetsx vrx is a multinational specialty pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology eye health neurology  and branded generics more information about valeant can be found at wwwvaleantcom forwardlooking statements this communication may contain forwardlooking statements within the meaning of the private securities litigation reform act of  and canadian securities laws  these forwardlooking statements include but are not limited to statements regarding valeants offer to acquire allergan its financing of the proposed transaction its expected future performance including expected results of operations and financial guidance and the combined companys future financial condition operating results strategy and plans  forwardlooking statements may be identified by the use of the words anticipates expects intends plans should could would may will believes estimates potential target opportunity tentative positioning designed create predict project seek ongoing upside increases or continue and variations or similar expressions these statements are based upon the current expectations and beliefs of management and are subject to numerous assumptions risks and uncertainties that change over time and could cause actual results to differ materially from those described in the forwardlooking statements  these assumptions risks and uncertainties include but are not limited to assumptions risks and uncertainties discussed in the companys most recent annual or quarterly report filed with the sec and the canadian securities administrators the csa and assumptions risks and uncertainties relating to the proposed merger as detailed from time to time in valeants filings with the sec and the csa which factors are incorporated herein by reference  important factors that could cause actual results to differ materially from the forwardlooking statements we make in this communication are set forth in other reports or documents that we file from time to time with the sec and the csa and include but are not limited to the ultimate outcome of the offer and the secondstep merger including the ultimate removal or the failure to render inapplicable the obstacles to consummation of the offer and the secondstep merger described in the offer to exchange the ultimate outcome and results of integrating the operations of valeant and allergan the ultimate outcome of valeants pricing and operating strategy applied to allergan and the ultimate ability to realize synergies the effects of the proposed combination of valeant and allergan including the combined companys future financial condition operating results strategy and plans the effects of governmental regulation on our business or potential business combination transactions the ability to obtain regulatory approvals and meet other conditions to the offer including the necessary stockholder approval on a timely basis valeants ability to sustain and grow revenues and cash flow from operations in our markets and to maintain and grow our customer base the need for innovation and the related capital expenditures and the unpredictable economic conditions in the united states and other markets the impact of competition from other market participants the development and commercialization of new products the availability and access in general of funds to meet our debt obligations prior to or when they become due and to fund our operations and necessary capital expenditures either through i cash on hand ii free cash flow or iii access to the capital or credit markets our ability to comply with all covenants in our indentures and credit facilities any violation of which if not cured in a timely manner could trigger a default of our other obligations under crossdefault provisions and the risks and uncertainties detailed by allergan with respect to its business as described in its reports and documents filed with the sec all forwardlooking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by this cautionary statement  readers are cautioned not to place undue reliance on any of these forwardlooking statements these forwardlooking statements speak only as of the date hereof  valeant undertakes no obligation to update any of these forwardlooking statements to reflect events or circumstances after the date of this communication or to reflect actual outcomes additional information this communication does not constitute an offer to buy or solicitation of an offer to sell any securities this communication relates to the exchange offer which valeant has made to allergan stockholders the exchange offer is being made pursuant to a tender offer statement on schedule to including the offer to exchange the letter of election and transmittal and other related offer materials and a registration statement on form s filed by valeant with the sec on june   and with the csa as each may be amended from time to time  these materials contain important information including the terms and conditions of the offer  in addition valeant has filed a preliminary proxy statement with the sec on june   as may be amended from time to time pershing square capital management lp pershing square has filed a definitive proxy statement with the sec on september   and valeant and pershing square and if a negotiated transaction is agreed allergan may file one or more additional proxy statements or other documents with the sec  this communication is not a substitute for any proxy statement registration statement prospectus or other document valeant pershing square andor allergan have filed or may file with the sec in connection with the proposed transaction investors and security holders of valeant and allergan are urged to read the tender offer statement registration statement and any other documents filed with the sec carefully in their entirety if and when they become available as they will contain important information about the proposed transaction any definitive proxy statements if and when available will be mailed to stockholders of allergan andor valeant as applicable investors and security holders may obtain free copies of the tender offer statement the registration statement and other documents if and when available filed with the sec by valeant andor pershing square through the web site maintained by the sec at httpwwwsecgov information regarding the names and interests in allergan and valeant of valeant and persons related to valeant who may be deemed participants in any solicitation of allergan or valeant shareholders in respect of a valeant proposal for a business combination with allergan is available in the additional definitive proxy soliciting materials in respect of allergan filed with the sec by valeant on april   may   and september    information regarding the names and interests in allergan and valeant of pershing square and persons related to pershing square who may be deemed participants in any solicitation of allergan or valeant shareholders in respect of a valeant proposal for a business combination with allergan is available in additional definitive proxy soliciting material in respect of allergan filed with the sec by pershing square  the additional definitive proxy soliciting material referred to in this paragraph can be obtained free of charge from the sources indicated above contact information valeant pharmaceuticals investors media laurie w little renee e sotomeghan gavigan valeant pharmaceuticals international inc sard verbinnen  co   laurielittlevaleantcom rsotosardverbcom  mgavigansardverbcom   logo  httpphotosprnewswirecomprnhlalogo source valeant pharmaceuticals international inc  back to news releases nysevrx tsx vrx copyright   valeant all rights reserved privacy policy terms  conditions site map jeffrey w ubben  san francisco ca  intelius sign in we found jeffrey w ubben in san francisco ca jeffrey w ubben intelius found that jeffrey w ubben is a male between  and  years old from san francisco ca we have connected them to  addresses  phones and  relatives or associates get report now age jeffrey w ubben is in his s jeffrey has lived in san francisco ca austin tx big sky mt jeffreys relatives charlotte ubben laura ubben josephine ubben jeffrey w ubben zodiac signcapricorn gendermale professional status chief executive officer at valueact capital get report now want to know more about jeffrey get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about jeffrey or use our people search engine to find others get background check on jeffrey w ubben get a criminal check on jeffrey w ubben get a public record report on jeffrey w ubben get a people search report on jeffrey w ubben jeffrey w ubbens contact information known cities lived in find out where jeffrey w ubben has lived as well as jeffrey w ubbens phone numbers and email addresses jeffrey w ubben has lived in  states california address for jeffrey w ubben  c s san francisco ca has lived in san francisco ca austin tx get full address report phone numbers associated with jeffrey w ubben    san francisco ca    san francisco ca    san francisco ca get full phone report email addresses associated with jeffrey w ubben jncom jncom jncom get email report jeffrey w ubbens professional information information regarding jeffrey w ubbens professional history find out previous places jeffrey w ubben has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act jeffrey w ubben has worked at  places company valueact capital title chief executive officer company valueact capital title director of information technology jeffrey w ubbens experience title chief executive officer company valueact capital job details company size  mil to less than  mil  employee range  to less than  title director of information technology company valueact capital job details company size  mil to less than  mil  employee range  to less than  additional professional information on jeffrey w ubben see jeffrey w ubbens linkedin profile jeffrey w ubbens social network and potential email matches find out potential social network profiles and potential email usernamed for jeffrey w ubben jeffrey w ubbens known social networks and potential email matches find all of jeffrey w ubbens social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches jeffrey ubben username matches jeffreyubben ubbenjeffrey jeffreyubben ubbenjeffrey jeffreyubben ubbenjeffrey jeffreyubben ubbenjeffrey jubben popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches j ubben intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals jeffrey w ubben ceo of valueact capital appointed to the board of valeant pharmaceuticals sep    et from valeant pharmaceuticals international inc valeant pharmaceuticals international inc prnewsfotovaleant pharmaceuticals international inc prnewsfoto     facebook twitter pinterest valeant pharmaceuticals international inc prnewsfotovaleant pharmaceuticals international inc prnewsfoto laval quebec sept   prnewswire  valeant pharmaceuticals international inc nysetsx vrx today announced that its board of directors has appointed jeffrey w ubben founder chief executive officer and the chief investment officer of valueact capital as a director of the board effective as of october   mr ubben is a founder chief executive officer and the chief investment officer of valueact capital prior to founding valueact capital in  mr ubben was a managing partner at blum capital partners for more than five years  mr ubben is a director of willis group holdings plc a former chairman and director of martha stewart living omnimedia inc and a former director of acxiom corp catalina marketing corp gartner group inc insurance auto auctions inc mentor corporation omnicare inc misys plc perse technologies inc sara lee corp and several other public and private companies  in addition mr ubben serves as chairman of the national board of the posse foundation is on the board of trustees of northwestern university and is also on the board of the american conservatory theater  mr ubben has a ba from duke university and an mba from the j l kellogg graduate school of management at northwestern university valueact is delighted to once again be a part of the valeant board of directors stated jeffrey w ubben chief executive officer of valueact capital  valeant has been an important component to valueacts success over the past seven years and we strongly believe in valeants business model and strategy valeant has become significantly undervalued on a standalone basis due to recent unjustified attacks on the company  we are strongly supportive of the allerganvaleant combination in light of their perfect strategic fit and the potential to create enormous shareholder value for both companies  valueact has not reduced its position in valeant since leaving the board in may and we expect to increase our already substantial position in valeant i look forward to working with mike and the board of directors to help secure the allergan transaction and then continuing to serve on the board to deliver longterm value to all shareholders it is a privilege and an honor to have jeff as valueacts most senior partner and the chief executive officer of valueact join our board stated j michael pearson chairman and chief executive officer of valeant  jeff believes in valeants longterm potential and his expertise and counsel as a committed longterm valeant shareholder will be invaluable to me personally as well as to the entire board as we continue to execute on our strategy to become a leading pharmaceutical company  it is incredibly valuable to have such a highly respected firm such as valueact whose focus is on longterm value creation to be completely aligned with us as we execute our strategy about valeant pharmaceuticals international inc valeant pharmaceuticals international inc nysetsx vrx is a multinational specialty pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology eye health neurology  and branded generics more information about valeant can be found at wwwvaleantcom forwardlooking statements this communication may contain forwardlooking statements within the meaning of the private securities litigation reform act of  and canadian securities laws  these forwardlooking statements include but are not limited to statements regarding valeants offer to acquire allergan its financing of the proposed transaction its expected future performance including expected results of operations and financial guidance and the combined companys future financial condition operating results strategy and plans  forwardlooking statements may be identified by the use of the words anticipates expects intends plans should could would may will believes estimates potential target opportunity tentative positioning designed create predict project seek ongoing upside increases or continue and variations or similar expressions these statements are based upon the current expectations and beliefs of management and are subject to numerous assumptions risks and uncertainties that change over time and could cause actual results to differ materially from those described in the forwardlooking statements  these assumptions risks and uncertainties include but are not limited to assumptions risks and uncertainties discussed in the companys most recent annual or quarterly report filed with the sec and the canadian securities administrators the csa and assumptions risks and uncertainties relating to the proposed merger as detailed from time to time in valeants filings with the sec and the csa which factors are incorporated herein by reference  important factors that could cause actual results to differ materially from the forwardlooking statements we make in this communication are set forth in other reports or documents that we file from time to time with the sec and the csa and include but are not limited to the ultimate outcome of the offer and the secondstep merger including the ultimate removal or the failure to render inapplicable the obstacles to consummation of the offer and the secondstep merger described in the offer to exchange the ultimate outcome and results of integrating the operations of valeant and allergan the ultimate outcome of valeants pricing and operating strategy applied to allergan and the ultimate ability to realize synergies the effects of the proposed combination of valeant and allergan including the combined companys future financial condition operating results strategy and plans the effects of governmental regulation on our business or potential business combination transactions the ability to obtain regulatory approvals and meet other conditions to the offer including the necessary stockholder approval on a timely basis valeants ability to sustain and grow revenues and cash flow from operations in our markets and to maintain and grow our customer base the need for innovation and the related capital expenditures and the unpredictable economic conditions in the united states and other markets the impact of competition from other market participants the development and commercialization of new products the availability and access in general of funds to meet our debt obligations prior to or when they become due and to fund our operations and necessary capital expenditures either through i cash on hand ii free cash flow or iii access to the capital or credit markets our ability to comply with all covenants in our indentures and credit facilities any violation of which if not cured in a timely manner could trigger a default of our other obligations under crossdefault provisions and the risks and uncertainties detailed by allergan with respect to its business as described in its reports and documents filed with the sec all forwardlooking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by this cautionary statement  readers are cautioned not to place undue reliance on any of these forwardlooking statements these forwardlooking statements speak only as of the date hereof  valeant undertakes no obligation to update any of these forwardlooking statements to reflect events or circumstances after the date of this communication or to reflect actual outcomes additional information this communication does not constitute an offer to buy or solicitation of an offer to sell any securities this communication relates to the exchange offer which valeant has made to allergan stockholders the exchange offer is being made pursuant to a tender offer statement on schedule to including the offer to exchange the letter of election and transmittal and other related offer materials and a registration statement on form s filed by valeant with the sec on june   and with the csa as each may be amended from time to time  these materials contain important information including the terms and conditions of the offer  in addition valeant has filed a preliminary proxy statement with the sec on june   as may be amended from time to time pershing square capital management lp pershing square has filed a definitive proxy statement with the sec on september   and valeant and pershing square and if a negotiated transaction is agreed allergan may file one or more additional proxy statements or other documents with the sec  this communication is not a substitute for any proxy statement registration statement prospectus or other document valeant pershing square andor allergan have filed or may file with the sec in connection with the proposed transaction investors and security holders of valeant and allergan are urged to read the tender offer statement registration statement and any other documents filed with the sec carefully in their entirety if and when they become available as they will contain important information about the proposed transaction any definitive proxy statements if and when available will be mailed to stockholders of allergan andor valeant as applicable investors and security holders may obtain free copies of the tender offer statement the registration statement and other documents if and when available filed with the sec by valeant andor pershing square through the web site maintained by the sec at httpwwwsecgov information regarding the names and interests in allergan and valeant of valeant and persons related to valeant who may be deemed participants in any solicitation of allergan or valeant shareholders in respect of a valeant proposal for a business combination with allergan is available in the additional definitive proxy soliciting materials in respect of allergan filed with the sec by valeant on april   may   and september    information regarding the names and interests in allergan and valeant of pershing square and persons related to pershing square who may be deemed participants in any solicitation of allergan or valeant shareholders in respect of a valeant proposal for a business combination with allergan is available in additional definitive proxy soliciting material in respect of allergan filed with the sec by pershing square  the additional definitive proxy soliciting material referred to in this paragraph can be obtained free of charge from the sources indicated above contact information valeant pharmaceuticals investors media laurie w little renee e sotomeghan gavigan valeant pharmaceuticals international inc sard verbinnen  co   laurielittlevaleantcom rsotosardverbcom  mgavigansardverbcom   logo  httpphotosprnewswirecomprnhlalogo source valeant pharmaceuticals international inc view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more sep    et preview bausch  lomb announces successful results from phase  study of submicron loteprednol etabonate ophthalmic gel  sep    et preview bausch  lomb and nicoxs glaucoma candidate vesneo® latanoprostene bunod meets primary endpoint in phase  studies my news release contains wide tables view fullscreen read more jul    et valeant agrees to sell obagi medical products business jul    et valeant announces redemption of remaining approximately  jul    et valeant announces q  financial results date and conference looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search jeffrey w ubben  wowcom home page search the web close menu wow web signin close my favorites view my favorites you have no favorite channelsto follow a channel click the if you wish to view your favorite channels from anywhere on the site click on the my favorites link at the top of the page manage my favorites home entertainment move menu left actors awards movies music tv tv shows music artists music genres books move menu right you might also like celebrity gossip game of thrones movie titles taylor swift health move menu left diets diseases drugs health law healthcare healthy living move menu right you might also like conditions az life stages mental health pregnancy tech move menu left apps computer hardware internet smart phones tablets move menu right you might also like windows  audio  video ereaders video games food move menu left allergies beverages cooking food movements safety move menu right you might also like organic food sustainable food homebrewing winemaking lifestyle move menu left celebrations fashion religion style travel  tourism move menu right you might also like mens fashion womens fashion beauty travel tips family move menu left adoption  planning marriage parenting pets move menu right you might also like relationships dating having a baby baby products sports move menu left nfl nba nhl mlb ncaa fb ncaa bb golf boxing soccer cycling motor sports swimming move menu right you might also like cricket extreme sports rugby tennis money move menu left business careers companies economy industries move menu right you might also like personal finance personal debt real estate retirement planning more move menu left arts education home  garden autos move menu right arts education home  garden autos surprise me  jeffrey w ubben source httpenwikipediaorgwikijeffreywubbenupdated tz jeffrey w ubbenbornjeffrey williams ubben age –nationalityamericanalma materduke universitykellogg school of managementoccupationbusinessmannet worthus million jeffrey williams ubben born  is an american businessman he is the cofounder chief executive officer and chief investment officer of valueact capital a hedge fund based in san francisco californiacontents early life business career philanthropy referencesearly lifejeffrey w ubben graduated from duke university he received a master of business administration from the kellogg school of management at northwestern university in business careerubben managed the fidelity value fund at fidelity investments for eight years he served as the managing partner of blum capital from  to ubben is the cofounder of valueact capital a hedge fund based in san francisco california in  he serves as its chief executive officer and chief investment officerubben formerly served on the boards of directors of acxiom gartner misys omnicare and the sara lee corporation he serves on the board of directors of the willis group in september  he was nominated to serve on the board of directors of st century foxin august  ubben acquired a minority stake in the united talent agencyphilanthropyubben serves as the chair of the national board of directors of the posse foundation he serves on the boards of trustees of northwestern university and the american conservatory theaterreferences a b c d e f company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october    ones to watch jeff urban forbes retrieved  october   a b c farell rachel alumni profiles jeff ubben  kellogg school of management retrieved october    a b c board of directors about willis retrieved october    hagey keach benoit david september   fox nominates valueact ceo jeffrey ubben to board ubben says netflixs industry impact is catalyst for fundamental change in strategy the wall street journal retrieved october    lang brent september   st century fox taps investor jeffrey ubben to join board variety retrieved october    barnes brooks august   jeffrey ubben buys minority stake in united talent agency the new york times retrieved october    company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october    trustees northwestern university retrieved october    board of trustees american conservatory theater retrieved october    text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy � wikipedia is a registered trademark of the wikimedia foundation inc a nonprofit organization also on wow check out more news about jeffrey ubben advertisement popular articles uk zoo donates white rhino eggs in ivf bid to save species jul   lindsay keeler  of the best handbags from the nordstrom anniversary sale jul   cristina corvino russias foreign minister says trump may have met putin jul   kamini ramdeen trumps legal team spokesman mark corallo resigns amid reported jul   christina gregg elon musk says he has verbal govt approval to build nydc jul   christina gregg give feedback  aol inc all rights reserved privacy  terms of use  about our ads share jeffrey w ubben  wikivisually wikivisually the entire wiki with video and photo galleriesfind something interesting to watch in seconds featured articles  · video picker · language · hover over links in text for more info click links in text for more info jeffrey w ubben from wikipedia the free encyclopedia jump to navigation search jeffrey w ubben born jeffrey williams ubben  age – nationality american alma mater duke university kellogg school of management occupation businessman net worth us million  jeffrey williams ubben born  is an american businessman he is the cofounder chief executive officer and chief investment officer of valueact capital a hedge fund based in san francisco california contents  early life  business career  philanthropy  references early lifeedit jeffrey w ubben graduated from duke university he received a master of business administration from the kellogg school of management at northwestern university in  business careeredit ubben managed the fidelity value fund at fidelity investments for eight years he served as the managing partner of blum capital from  to  ubben is the cofounder of valueact capital a hedge fund based in san francisco california in  he serves as its chief executive officer and chief investment officer ubben formerly served on the boards of directors of acxiom gartner misys omnicare and the sara lee corporation he serves on the board of directors of the willis group in september  he was nominated to serve on the board of directors of st century fox in august  ubben acquired a minority stake in the united talent agency philanthropyedit ubben serves as the chair of the national board of directors of the posse foundation he serves on the boards of trustees of northwestern university and the american conservatory theater referencesedit  a b c d e f company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     ones to watch jeff urban forbes retrieved  october    a b c farell rachel alumni profiles jeff ubben ’ kellogg school of management retrieved october     a b c board of directors about willis retrieved october     hagey keach benoit david september   fox nominates valueact ceo jeffrey ubben to board ubben says netflix’s industry impact is catalyst for ‘fundamental change in strategy’ the wall street journal retrieved october     lang brent september   st century fox taps investor jeffrey ubben to join board variety retrieved october     barnes brooks august   jeffrey ubben buys minority stake in united talent agency the new york times retrieved october     company overview of valueact capital partners lp jeffrey williams ubben bloomberg business retrieved october     trustees northwestern university retrieved october     board of trustees american conservatory theater retrieved october    retrieved from httpsenwikipediaorgwindexphptitlejeffreywubbenoldid categories  birthsliving peopleduke university alumnikellogg school of management alumniamerican company foundersamerican chief executivesamerican hedge fund managersamerican corporate directorschief investment officershidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view hide videos list of images loading jeff ubben  ones to watch  forbes connect  sign up  log in  stocks to buy now forbes  richest americans sponsored by ones to watch bert tito beveridge  ann johansson for the new york timesredux jeff ubben est net worth  million age  source hedge funds hedge fund investor jumped into the news this summer when his valueact capital which he founded in  took on microsoft and steve ballmer it pushed for and got a seat on microsoft’s board and agreed not to wage a proxy battle some think his team even led to ballmer’s resignation chairs the posse foundation which provides college scholarships to select high school seniors full coverage of the forbes  the wealthiest people in america buoyed by public markets the average net worth of  us richest rose  million to a record  billion microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates amazoncom amazon music unlimited interesting finds updated daily amazon try prime digital music all departments alexa skills amazon devices amazon video amazon warehouse deals appliances apps  games arts crafts  sewing automotive parts  accessories baby beauty  personal care books cds  vinyl cell phones  accessories clothing shoes  jewelry    women    men    girls    boys    baby collectibles  fine art computers courses credit and payment cards digital music electronics gift cards grocery  gourmet food handmade health household  baby care home  business services home  kitchen industrial  scientific kindle store luggage  travel gear luxury beauty magazine subscriptions movies  tv musical instruments office products patio lawn  garden pet supplies prime exclusive prime pantry software sports  outdoors tools  home improvement toys  games vehicles video games wine go departments en   hello sign inaccount  listssign inaccount  listsorderstry primecart your amazoncomtodays dealsgift cards  registrysellhelpdisability customer support amazon music unlimited prime music cds  vinyl download store open web player mp cart settings mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial theres a problem loading this menu right now learn more about amazon prime get fast free shipping with amazon prime prime members enjoy free twoday shipping and exclusive access to music movies tv shows original audio series and kindle books  get started v robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates